OpenAI has stopped taking new Pro subscribers because its Astra product is straining the company's infrastructure, according to TechCrunch. That's a strange problem to have in public: the most valuable AI company in the world telling paying customers to wait in line. But it's also an honest one. Compute is not infinite, and when demand for a flagship feature spikes faster than data centers can be racked and powered, something has to give. OpenAI chose to protect the experience for existing users over growing the top line, which is the right call, but it also exposes how thin the margin for error is right now across the industry. Any business leaning on a single AI vendor for mission-critical workflows should treat this as a reminder that capacity, not just capability, is a real vendor-selection criterion. It's part of why we keep telling teams evaluating a no-code app builder to ask not just what a tool can do, but whether it can do it reliably at scale when everyone else wants the same thing at once.
Anthropic published a report Thursday accusing Alibaba, Moonshot AI, and DeepSeek of running sustained distillation campaigns against its models, per TechCrunch -- essentially training cheaper models on Claude's outputs to shortcut the expensive work of building frontier AI from scratch. Anthropic says these attempts have intensified as competition has heated up. Distillation isn't new or automatically illegal, but the accusation that it's escalating and coordinated is a pointed one, and it lands squarely in the middle of the US-China AI rivalry that's been building all year. For a business reader, the interesting part isn't the geopolitics, it's what this says about the durability of any single model's advantage. If a frontier lab's outputs can be siphoned off and reproduced at a fraction of the training cost, the moat that justifies premium pricing gets thinner every quarter. That's a good argument for building your operations on a flexible platform rather than betting the business on any one model staying ahead of its imitators -- which is exactly the case we make in Buy vs. Build vs. ViibeStack.
OpenAI is adding Paul Christiano, a well-known alignment researcher who has been publicly candid about existential AI risk, to the board of the OpenAI Foundation, TechCrunch reported. Call him a doomer if you like, but putting someone whose entire career has been about what could go wrong with powerful AI onto the body that oversees the company is a meaningful signal, whether or not you think the doom scenarios are realistic. It suggests OpenAI's leadership feels enough heat, from regulators, from the public, from its own researchers, that it wants a credible skeptic in the room rather than another cheerleader. Skeptics of the move will note that a single board seat doesn't change incentives at a company racing to ship product and raise capital, and that's a fair point. But symbolically, this fits a pattern we've been tracking, including in our look at OpenAI's board and who's actually accountable when AI agents misbehave. Governance is becoming a genuine competitive and reputational variable, not just a compliance checkbox, and businesses choosing AI vendors should be paying attention to who sits on those boards, not just what the models can do.
If you had to bet, which of these three stories -- the capacity crunch, the distillation fight, or the new boardroom skeptic -- will matter most to your business a year from now, and why?
Sources